All Antivenoms Are Not Created Equal

Journalist Léa Surugue does not mince words: “The antivenom field is, in short, a disaster.”
Every year, some 100,000 people die from venomous snakebite.
In 2017 WHO acknowledged venomous snakebite as a neglected tropical disease, and researchers are seeking new treatments.
But for now, there’s not nearly enough antivenom to go around, and treatment is finnicky: Was it the right antivenom? Was it administered quickly enough? Correctly?

These challenges beget more challenges: People stop seeking treatment, funding drops, prices rise and substandard products flood the market, culminating in perhaps the biggest problem of all: antivenom mistrust.

Comments +


Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top